K2M Group Launches 3D-printed CASCADIA Lateral Interbody System
Executive Summary
K2M Group’s CASCADIA incorporates 3D printing for its Lamellar Titanium Technology to allow for bony integration throughout the implant. Surgeons now have a new alternative to traditional PEEK and titanium cages for the 90,000 spinal lateral fusion procedures performed globally each year, a market estimated at $500 million.
You may also be interested in...
3D Printing: Will Personalized Medical Devices Be The Next Big Thing?
Medical device manufacturers have a growing interest in 3D printing, a technology that could upend the manufacturing and distribution of certain medical devices and expand the scope of personalized medicine – especially in orthopedics, where it's used for some models, implants, and surgical cutting guides. Despite uncertainties related to regulation, reimbursement, and scaling up, global 3D printing revenues for medical and dental applications reached an estimated $537.1 million in 2014.
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.